Global Biofeedback Measurement Instrument Market, by Type (Brainwaves, Heart Rate, Muscles, Sweat Glands, and Others), By End User (Hospitals, Clinics, Home Settings, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 148.68 million in 2019 and is expected to exhibit a CAGR of 6.2% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/3781
Biofeedback is the use of electronic or electromechanical equipment (usually computer-based) that helps to measure and provide feedback about physiological processes. The aim of biofeedback is to make patients aware about the different states of physiologic arousal and patients’ ability to control physiologic changes in their bodies. Goals of biofeedback treatment also includes improvement of the pediatric patient’s ability to distinguish and cultivate lower levels of sympathetic nervous system arousal and achieve a balanced state of mind-body.
The increasing incidence of neurological disorders is expected to propel growth of the market during the forecast period. For instance, according to a report published by the World Health Organization (WHO) in 2016, there are 7.7 million new cases of dementia every year across the globe. Moreover, Alzheimer’s disease, which is the most common cause of dementia, accounts for 60 to 70% of dementia cases. Furthermore, according to the Mindgardens Neuroscience Network, the leading cause of disability in Australia in 2017 was mental and neurological disorders, which accounted for 20.5% of the total Australian daily adjusted life years (DALYs).
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3781
Asia Pacific is expected to offer lucrative growth opportunities for players operating in the biofeedback measurement instrument market owing to the rising incidence of CNS disorders in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), in 2018 reports that the burden of dementia in Japan is growing and it is expected that 1 in 5 elderly people will suffer from dementia in Japan by 2025.
Moreover, the growing patient pool with neurological disorders in this region is expected to drive growth of the market during the forecast period. For instance, according to the Mindgardens Neuroscience Network, in 2017, the total prevalence of neurological disorders in Australia was 10.6 million (43.0%), followed by 4 million (16.3%) for mental health disorders, and 0.8 million (3.2.0%) for substance disorders.
Browse 20 Market Data Tables and 16 Figures spread through 150 Pages and in-depth TOC on “Biofeedback Measurement Instrument Market” – Global forecast to 2027, by Type (Brainwaves, Heart Rate, Muscles, Sweat Glands, and Others), by End User (Hospitals, Clinics, Home Settings, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the Biofeedback Measurement Instrument Market press release, click the link below: https://www.coherentmarketinsights.com/press-release/biofeedback-measurement-instrument-market-3047
Key Takeaways of the Biofeedback Measurement Instrument Market:
- The global biofeedback measurement instrument market is expected to exhibit a CAGR of 6.2% over the forecast period owing to an increasing number of depression cases. According to Our World in Data – a project of the Global Change Data Lab, the study estimates that in 2017, nearly 792 million people were suffering with mental health disorder in 2017 in North America.
- Among type segment, brainwaves held dominant position in the biofeedback measurement instrument market in 2018 owing to the rising incidence of mental disorders. According to the Global Burden of Disease, in 2017 there were 264 million individuals were suffering through depression.
- Among end user, hospitals segment held dominant position in the biofeedback measurement instrument market in 2019 owing to growing number neurological disorders. For instance, according to the Mindgardens Neuroscience Network, in 2017, neurological, mental health, and substance abuse disorders accounted for 11.1% of the global burden of disease.
- The companies operating in the global biofeedback measurement instrument market are Thought Technology Ltd., ELMIKO, Mind Media, Laborie, Behavioral Medicine Associates, Inc., Neurocare Group Gmbh., Allengers Medical Systems, BrainMaster Technologies, Inc., Quantum World Vision, NCC Medical, Qxsubspace, and others.
Detailed Segmentation:
- Global Biofeedback Measurement Instrument market, By Type:
- Brainwaves
- Heart Rate
- Muscles
- Sweat Glands
- Others
- Global Biofeedback Measurement Instrument market, By End User:
- Hospitals
- Clinics
- Home Settings
- Ambulatory Surgical Centers
- Global Biofeedback Measurement Instrument market, By Region:
- North America
- By Type:
- Brainwaves
- Heart Rate
- Muscles
- Sweat Glands
- Others
- By End User:
- Hospitals
- Clinics
- Home Settings
- Ambulatory Surgical Centers
- By Country:
- U.S.
- Canada
- By Type:
- Latin America
- By Type:
- By End User:
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Type:
- By End User:
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Type:
- By End User:
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- By Type:
- By End User:
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Type:
- By End User:
- By Country/Region:
- North Africa
- Central Africa
- South Africa
- North America
- Company Profiles
- Thought Technology Ltd.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ELMIKO
- Mind Media
- Laborie
- Behavioral Medicine Associates, Inc.
- Neurocare Group Gmbh.
- Allengers Medical Systems
- BrainMaster Technologies, Inc.
- Quantum World Vision
- NCC Medical
- Qxsubspace
- Thought Technology Ltd.*
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
